Valued at a market cap of $21.2 billion, Moderna, Inc. (MRNA) is a biotechnology company that pioneered the use of messenger ...

Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...

Moderna MRNA shares are moving higher on Monday after the company won FDA Fast Track status for an oncology program, helping ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...

Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...

The U.S. FDA has granted Fast Track designation for mRNA-4359 in combination with pembrolizumab for the treatment of ...

Moderna, Inc. recently participated in the 5th LNP Formulation & Process Development Summit in Boston and scheduled a May 1, ...

The US drugmaker said it was informed by the Data Safety Monitoring Board that its vaccine had met statistical criteria ...

Production of Moderna COVID-19 vaccines at a plant in Spain can continue, the European Union drugs regulator said on Friday, ...

Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses to the US.

That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...

After the Food and Drug Administration initially declined to review Moderna's mRNA flu vaccine candidate, the drugmaker said Wednesday that the FDA reversed its decision and will allow Moderna to move ...